| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |